These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 4149403)
41. Induction of benzpyrene hydroxylase in fetal liver explants by flavones and phenobarbital. Cutroneo KR; Bresnick E Biochem Pharmacol; 1973 Mar; 22(6):675-87. PubMed ID: 4693491 [No Abstract] [Full Text] [Related]
42. Alterations in the toxicity of thiodemeton due to the pretreatment of inducers, substrates and inhibitors of mixed function oxidase system. Pawar SS; Fawade MM Bull Environ Contam Toxicol; 1978 Dec; 20(6):805-10. PubMed ID: 749979 [No Abstract] [Full Text] [Related]
43. [6 beta-hydroxycortisol: a non-invasive reflection of enzymes of drug metabolism]. Zhiri A; Wellman-Bednawska M; Siest G Pathol Biol (Paris); 1987 Sep; 35(7):1087-93. PubMed ID: 3313218 [TBL] [Abstract][Full Text] [Related]
44. Nutrient and non-nutrient effects on drug metabolism. Hathcock JN Drug Nutr Interact; 1985; 4(1-2):217-34. PubMed ID: 3908043 [No Abstract] [Full Text] [Related]
45. Different changes on hepatic drug-metabolizing system caused by non-steroid anti-inflammatory drugs. Fracasso ME; Gasperini R; Leone R Acta Physiol Hung; 1990; 75 Suppl():109-10. PubMed ID: 2371835 [No Abstract] [Full Text] [Related]
46. The effect of mixed function oxidase induction and inhibition on salicylate-induced nephrotoxicity in male rats. Kyle ME; Kocsis JJ Toxicol Appl Pharmacol; 1986 Jun; 84(2):241-9. PubMed ID: 3715872 [TBL] [Abstract][Full Text] [Related]
47. Effects of administration of metabolic inducers and inhibitors on pulmonary toxicity and covalent binding by 1,1-dichloroethylene in CD-1 mice. Forkert PG; Stringer V; Racz WJ Exp Mol Pathol; 1986 Aug; 45(1):44-58. PubMed ID: 3758307 [TBL] [Abstract][Full Text] [Related]
48. Practolol: aspects of its metabolism and ocular binding in the hamster. Rosenbaum SE; Lindup WE; Orton TC Xenobiotica; 1986 Jun; 16(6):567-73. PubMed ID: 3751112 [TBL] [Abstract][Full Text] [Related]
49. Induction of drug-metabolizing enzymes and cytochrome P-450. Long RF Biochem J; 1969 Dec; 115(5):26P. PubMed ID: 5360681 [No Abstract] [Full Text] [Related]
50. A comparison of the properties in vitro of biphenyl 2- and 4-hydroxylase in the mesocarp from avocado pear (Persea americana) and Syrian-hamster hepatic tissue. McPherson FJ; Markham A; Bridges JW; Hartman GC; Parke DV Biochem Soc Trans; 1975; 3(2):281-3. PubMed ID: 1132558 [No Abstract] [Full Text] [Related]
51. Hepatic drug metabolism after phenobarbital and diphenylhydantoin administration in the rat--influence of vitamin D3 status. Gascon-Barré M; Côte MG; Brodeur J Biochem Pharmacol; 1979; 28(2):313-9. PubMed ID: 218591 [No Abstract] [Full Text] [Related]
52. The effect of prolonged sodium phenobarbitone treatment on hepatic xenobiotic metabolism and the urinary excretion of metabolites of the D-glucuronic acid pathway in the rat. Lake BG; Longland RC; Harris RA; Severn BJ; Gangolli SD Biochem Pharmacol; 1978; 27(19):2357-61. PubMed ID: 728187 [No Abstract] [Full Text] [Related]
53. Drug metabolism and therapeutics. Conney AH N Engl J Med; 1969 Mar; 280(12):653-60. PubMed ID: 4974536 [No Abstract] [Full Text] [Related]
54. Effect of benzo( )pyrene treatment on the benzo( )pyrene hydroxylase activity in maternal liver, placenta, and fetus of the rat during day 13 to day 18 of gestation. Schlede E; Merker HJ Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(1):89-100. PubMed ID: 4257474 [No Abstract] [Full Text] [Related]
55. Subchronic effects of piperonyl butoxide on carcinogen metabolism in hamster liver. Friedman MA Bull Environ Contam Toxicol; 1979 Apr; 21(6):815-21. PubMed ID: 465762 [No Abstract] [Full Text] [Related]
56. Attempts to induce drug metabolism in human fetal liver and placenta by the administration of phenobarbital to mothers. Pelkonen O; Jouppila P; Kärki NT Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):288-97. PubMed ID: 4694366 [No Abstract] [Full Text] [Related]
57. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. Mitchell JR; Jollow DJ; Potter WZ; Davis DC; Gillette JR; Brodie BB J Pharmacol Exp Ther; 1973 Oct; 187(1):185-94. PubMed ID: 4746326 [No Abstract] [Full Text] [Related]
58. Drug metabolism in the newborn. Eriksson M; Yaffe SJ Annu Rev Med; 1973; 24():29-40. PubMed ID: 4581909 [No Abstract] [Full Text] [Related]
59. Categorization of lipophilic xenobiotics by the enthalpic structure-function response of hepatic mixed-function oxidase. Hollebone BR Drug Metab Rev; 1986; 17(1-2):93-143. PubMed ID: 3536381 [No Abstract] [Full Text] [Related]
60. Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Jollow DJ; Thorgeirsson SS; Potter WZ; Hashimoto M; Mitchell JR Pharmacology; 1974; 12(4-5):251-71. PubMed ID: 4449889 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]